Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity.
about
Novel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injuryTransglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS blockThe impact of biosampling procedures on molecular data interpretationEpigenetic impact of curcumin on stroke preventionRegulation of neuronal bioenergy homeostasis by glutamateA selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related testsYin Yang 1 is a repressor of glutamate transporter EAAT2, and it mediates manganese-induced decrease of EAAT2 expression in astrocytesEpigenetics: an expanding new piece of the stroke puzzleEpigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammationMechanism of raloxifene-induced upregulation of glutamate transporters in rat primary astrocytesChanges in gap junction expression and function following ischemic injury of spinal cord white matterHistone deacetylase expression in white matter oligodendrocytes after strokeExpression of histone deacetylases in cellular compartments of the mouse brain and the effects of ischemia.HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.Valproic acid increases white matter repair and neurogenesis after stroke.Histone deacetylase inhibitors preserve function in aging axons.White matter injury in the preterm infant: pathology and mechanisms.Epigenetic mechanisms in stroke and epilepsy.Epigenetic mechanisms in neurological diseaseHDAC3 is a negative regulator of cocaine-context-associated memory formation.Epigenetic mechanisms in cerebral ischemia.Synaptic activity and bioenergy homeostasis: implications in brain trauma and neurodegenerative diseases.Proteolipid protein-deficient myelin promotes axonal mitochondrial dysfunction via altered metabolic coupling.Epigenetic determinants of healthy and diseased brain aging and cognition.Mitochondrial mechanisms of neuroglobin's neuroprotection.Age-related changes in the visual pathways: blame it on the axon.Post-stroke recovery: the role of activity-dependent release of brain-derived neurotrophic factor.The Emerging Role of Epigenetics in Cerebral Ischemia.Glutamate and ATP at the Interface Between Signaling and Metabolism in Astroglia: Examples from Pathology.Sodium Butyrate, a Histone Deacetylase Inhibitor, Exhibits Neuroprotective/Neurogenic Effects in a Rat Model of Neonatal Hypoxia-Ischemia.Implications of Epigenetic Mechanisms and their Targets in Cerebral Ischemia Models.Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+.Age-Related Changes in Axonal and Mitochondrial Ultrastructure and Function in White Matter.Histone Deacetylase Inhibitors and Mithramycin A Impact a Similar Neuroprotective Pathway at a Crossroad between Cancer and Neurodegeneration.In vitro characterization of mitochondrial function and structure in rat and human cells with a deficiency of the NADH: ubiquinone oxidoreductase Ndufc2 subunit.Manganese Control of Glutamate Transporters' Gene Expression.Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways.MS-275, a class I histone deacetylase inhibitor, protects the p53-deficient mouse against ischemic injury.Brain injury in premature neonates: A primary cerebral dysmaturation disorder?
P2860
Q26824369-C7CCE996-D0C4-4DF2-BB23-73E2F98F63EFQ26824549-B23B7C76-1B0B-44FB-A555-3A61F2ABF738Q26991764-B273D345-46BB-4388-9533-4926D4FD3A53Q26995412-9BC822FA-0F64-466A-9382-0655364371B2Q28388014-99B68F0E-BAF1-4B98-806C-FD3E23BCF0E9Q28535325-C1DA7031-8802-4AD5-BB37-E4ABA367AF5BQ28583893-A576BD4A-1B94-4FCB-A874-A61F53384713Q33352309-69C9D2AC-B797-4D31-BCDC-7470BA13B18AQ33693885-68231631-AEC4-469E-B030-FA9B26D8E77EQ33757971-693FAC5A-0B37-47E1-A6C0-586240A08236Q33769843-60CBB594-893D-4514-A808-B8762BA78DEFQ34763071-24EBAE94-6AE9-4C0A-BE2F-6C338CF73FE8Q35096305-D48EDE70-3203-4E68-AA2A-62EE61ABE748Q35237734-803ABF77-C14A-4D54-B8EF-445CE58021AAQ35380239-02939EB5-A3F3-443C-BB3A-8B5A05620255Q36143758-ECFF204F-744D-4C4E-A90F-57D3575FB964Q36347335-A3DD9BF0-53A3-4D88-99C0-4E9AB7679A8EQ36378391-92A32675-C83C-4EFE-A047-7336FD7F17B9Q36465823-24C40251-CD2E-42FF-AA22-75255AABA065Q36682567-BEBB4B65-E6EB-4BE1-9AEF-864A93B79D03Q36896817-5CFDF620-6C9C-447E-906F-49058BF197E1Q37150340-E58426BD-30B1-4FD2-998A-9D6978A6E88FQ37382205-DEE52AAE-2969-4182-B2D4-42A39C83A618Q37429858-4D800F5C-4B36-4A76-A77D-319280C96545Q37598709-314D8E18-4F89-42BA-B718-709BD9418A43Q38103249-0EEBFB19-7D83-4F87-B3B5-FED01F9B98FEQ38170997-F0FE1A83-2D07-4126-A491-DBCC6F854FF0Q38260556-E58471B0-39AD-4A31-BD1F-CD074CD3A14BQ38740709-00E82B55-BE6A-4E8F-971B-F155E4201E83Q38750023-A04B8D51-04BE-4215-AA18-C1F9EF2F75E0Q38826149-D0A39EC0-0161-4C15-AAC6-CC70C791B032Q39037754-1CC5AE28-F8B0-4B44-BBD9-DF5F7C534BB6Q39042148-4994DAFB-843E-4338-8B0D-FFF7A25AFA60Q41200545-8619A43D-2890-45FD-8EAE-3AE3D50C0A1DQ42155982-26FF49E3-4F1B-49FE-AD5B-124936E341C3Q46295972-FB97C212-1B33-4D03-AFE5-6B693DCF7416Q47923208-43BE6BC4-6E97-4A93-AD64-3DCAA8A9FD40Q47947143-313E7735-5657-49E5-85B5-D389DDEEC85AQ48919917-5F4C4D1F-5DBB-42E4-AC07-73F89E92261DQ50680469-7AB44F49-8549-43B9-884D-0EB81D06668B
P2860
Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Histone deacetylase inhibitors ...... P and reducing excitotoxicity.
@en
type
label
Histone deacetylase inhibitors ...... P and reducing excitotoxicity.
@en
prefLabel
Histone deacetylase inhibitors ...... P and reducing excitotoxicity.
@en
P2093
P2860
P1476
Histone deacetylase inhibitors ...... P and reducing excitotoxicity.
@en
P2093
Amelia Bachleda
Camelia A Danilov
Richard S Morrison
Sean P Murphy
Selva Baltan
P2860
P304
P356
10.1523/JNEUROSCI.5379-10.2011
P407
P577
2011-03-01T00:00:00Z